Concepedia

Thomas Wiglenda

TW

12

Publications

1.1K

Citations

11

H-Index

2002

Active since

Affiliations

Max Delbrück Center(Current)

Freie Universität Berlin

Charité - Universitätsmedizin Berlin

Max Planck Institute for Molecular Genetics

Thomas Wiglenda is an author at Max Delbrück Center specializing in medicine, neurodegenerative diseases, and biochemistry.

ORCID

Top concepts

Publications per year

2002–2020

12

Publications

12

Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils

Jan Bieschke, Martin Herbst, Thomas Wiglenda et al. · Nature Chemical Biology · 2011 · 438 citations

, , +4

Antitumor-Active Cobalt−Alkyne Complexes Derived from Acetylsalicylic Acid:  Studies on the Mode of Drug Action

Ingo Ott, Kathrin Schmidt, Brigitte Kircher et al. · Journal of Medicinal Chemistry · 2004 · 205 citations

Structure−Activity Relationship Study To Understand the Estrogen Receptor-Dependent Gene Activation of Aryl- and Alkyl-Substituted 1<i>H</i>-Imidazoles

Thomas Wiglenda, Ronald Gust · Journal of Medicinal Chemistry · 2007 · 84 citations

Synthesis and Pharmacological Evaluation of 1<i>H</i>-Imidazoles as Ligands for the Estrogen Receptor and Cytotoxic Inhibitors of the Cyclooxygenase

Thomas Wiglenda, Ingo Ott, Brigitte Kircher et al. · Journal of Medicinal Chemistry · 2005 · 71 citations · Full text

Mixing Aβ(1–40) and Aβ(1–42) peptides generates unique amyloid fibrils

Linda Cerofolini, Enrico Ravera, Sara Bologna et al. · Chemical Communications · 2020 · 59 citations · Full text

, , +17

Rows per page

1–5 of 12